BigBearai Holdings Inc vs Cardinal Health Inc — how do they compare? BigBearai Holdings Inc trades at $3.34 (market cap $1.55B), while Cardinal Health Inc trades at $240.52 (market cap $55.55B). The key difference: Cardinal Health Inc is far larger — about 35.8× BigBearai Holdings Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while BigBearai Holdings Inc pays none. Which is the better fit depends on your goals.
| BBAI | CAH | |
|---|---|---|
Market Cap | $1.55B | $55.55B |
Sector | Technology | Health |
52-Week High | $8.91 | $240.26 |
52-Week Low | $2.61 | $146.04 |
Enterprise Value | $1.25B | $60.53B |
Dividend Yield | — | 0.86% |
Signals from Pluang's Aura AI — not financial advice
BBAI trades at $3.27, up 8.64% with a bullish technical signal despite negative profitability metrics. The company reported Q2 2026 revenue growth of 13% and beat EPS estimates, though it remains unprofitable with a -65.2% net income margin. Recent news highlights defense contract execution and generative AI platform expansion for government clients.
The outlook remains challenging due to persistent losses and negative cash flow from operations, though analyst consensus leans neutral with 75% hold ratings. Key risks include execution on government contracts and achieving profitability, while technical indicators suggest near-term bullish momentum.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →